InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
-29.3%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by SCHADE CHRISTIAN S, Chairman & CEO. Officer active across 2 companies, notably Integra Lifesciences Holdings CORP. In total, 11 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €23k. Activity tracked since 14 May 2021. The latest transaction was filed on 9 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations11 total
6,939 shares0Common StockSEC:0000917520-25-000044:0
8,696 shares0Common StockSEC:0001628280-24-022923:0
4,486 shares0Common StockSEC:0001209191-23-029792:0
32,400 shares0Common StockSEC:0001104659-22-084772:0
65,770 shares@ US$0.8050.83% mcap46.5% of flowCommon StockSEC:0001104659-22-069015:0
37,500 shares@ US$0.64330.39% mcap21.7% of flowCommon StockSEC:0001104659-22-062916:0
Canonical exit: 16 Aug 2022 (T+90)
1,265 shares0Common StockSEC:0001209191-22-029707:0
100,100 shares0Common StockSEC:0001104659-22-033393:0
21,644 shares@ US$1.740.56% mcap31.8% of flowCommon StockSEC:0001104659-22-028767:0
530 shares0Common StockSEC:0001209191-21-033148
530 shares0Common StockSEC:0001209191-21-033148:0
11 of 11 declarations
About SCHADE CHRISTIAN S
Christian S. Schade is a Director and Chairman & CEO at INTEGRA LIFESCIENCES HOLDINGS CORP and Aprea Therapeutics, Inc. His leadership is essential for the strategic direction of the companies.
